M&A Deal Summary

Organon Acquires Dermavant Sciences

On September 18, 2024, Organon acquired medical products company Dermavant Sciences for 1.2B USD

Acquisition Highlights
  • This is Organon’s 2nd transaction in the Medical Products sector.
  • This is Organon’s largest (disclosed) transaction.
  • This is Organon’s 2nd transaction in the United States.
  • This is Organon’s 2nd transaction in California.

M&A Deal Summary
Date 2024-09-18
Target Dermavant Sciences
Sector Medical Products
Buyer(s) Organon
Deal Type Add-on Acquisition
Deal Value 1.2B USD

Target

Dermavant Sciences

Long Beach, California, United States
Dermavant Sciences is focused on developing and commercializing innovative therapeutics in immuno-dermatology. The company’s medical dermatology pipeline includes earlier-development, late-stage, and commercialized, product candidates that target specific unmet needs in growing immuno-dermatology markets, plaque psoriasis and atopic dermatitis, as well as other immunological and inflammatory diseases. It markets VTAMA (tapinarof) cream, 1%, for the topical treatment of plaque psoriasis in adults. Dermavant Sciences is based in Long Beach, California.

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Organon

Jersey City, New Jersey, United States
Category Company
Sector Healthcare Services
Revenue 6.3B USD (2023)
DESCRIPTION

Organon develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health. Organon is based in Jersey City, New Jersey.

DEAL STATS #
Overall 3 of 3
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 3 of 3
State (California) 2 of 2
Country (United States) 2 of 2
Year (2024) 1 of 1
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-11 Forendo Pharma

Turku, Finland

Forendo Pharma is a clinical-stage drug development company focused on novel treatments in women’s health. Forendo Pharma is based in Turku, Finland.

Buy $75M
Mergr

Product

Company

Legal